Cardiac stem cell therapy may heal heart damage caused by Duchenne muscular dystrophy
Late-breaking basic science research presented at American Heart Association Scientific Sessions shows stem cell treatment restores heart function damaged by muscular disease
2014-11-18
(Press-News.org) LOS ANGELES (NOV. 17, 2014) - Researchers at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells might help reverse heart damage caused by Duchenne muscular dystrophy, potentially resulting in a longer life expectancy for patients with the chronic muscle-wasting disease.
The study results were presented today at a Breaking Basic Science presentation during the American Heart Association Scientific Sessions in Chicago. After laboratory mice with Duchenne muscular dystrophy were infused with cardiac stem cells, the mice showed steady, marked improvement in heart function and increased exercise capacity.
Duchenne muscular dystrophy, which affects 1 in 3,600 boys, is a neuromuscular disease caused by a shortage of a protein called dystrophin, leading to progressive muscle weakness. Most Duchenne patients lose their ability to walk by age 12. Average life expectancy is about 25. The cause of death often is heart failure because the dystrophin deficiency leads to cardiomyopathy, a weakness of the heart muscle that makes the heart less able to pump blood and maintain a regular rhythm.
"Most research into treatments for Duchenne muscular dystrophy patients has focused on the skeletal muscle aspects of the disease, but more often than not, the cause of death has been the heart failure that affects Duchenne patients," said Eduardo Marbán, MD, PhD, director of the Cedars-Sinai Heart Institute and study leader. "Currently, there is no treatment to address the loss of functional heart muscle in these patients."
During the past five years, the Cedars-Sinai Heart Institute has become a world leader in studying the use of stem cells to regenerate heart muscle in patients who have had heart attacks. In 2009, Marbán and his team completed the world's first procedure in which a patient's own heart tissue was used to grow specialized heart stem cells. The specialized cells were then injected back into the patient's heart in an effort to repair and regrow healthy muscle in a heart that had been injured by a heart attack. Results, published in The Lancet in 2012, showed that one year after receiving the experimental stem cell treatment, heart attack patients demonstrated a significant reduction in the size of the scar left on the heart muscle.
Earlier this year, Heart Institute researchers began a new study, called ALLSTAR, in which heart attack patients are being infused with allogeneic stem cells, which are derived from donor-quality hearts.
Recently, the Heart Institute opened the nation's first Regenerative Medicine Clinic, designed to match heart and vascular disease patients with appropriate stem cell clinical trials being conducted at Cedars-Sinai and other institutions.
"We are committed to thoroughly investigating whether stem cells could repair heart damage caused by Duchenne muscular dystrophy," Marbán said.
In the study, 78 lab mice were injected with cardiac stem cells. Over the next three months, the lab mice demonstrated improved pumping ability and exercise capacity in addition to a reduction in heart inflammation. The researchers also discovered that the stem cells work indirectly, by secreting tiny fat droplets called exosomes. The exosomes, when purified and administered alone, reproduce the key benefits of the cardiac stem cells.
Marbán said the procedure could be ready for testing in human clinical studies as soon as next year.
The process to grow cardiac-derived stem cells was developed by Marbán when he was on the faculty of Johns Hopkins University. Johns Hopkins has filed for a patent on that intellectual property and has licensed it to Capricor, a company in which Cedars-Sinai and Marbán have a financial interest. Capricor is providing funds for the ALLSTAR clinical trial at Cedars-Sinai.
The Cedars-Sinai Heart Institute has been at the forefront of developing investigational stem cell treatments for heart attack patients.
INFORMATION:
About the Cedars-Sinai Heart Institute
The Cedars-Sinai Heart Institute is internationally recognized for outstanding heart care built on decades of innovation and leading-edge research. From cardiac imaging and advanced diagnostics to surgical repair of complex heart problems to the training of the heart specialists of tomorrow and research that is deepening medical knowledge and practice, the Cedars-Sinai Heart Institute is known around the world for excellence and innovations.
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-18
Results of a new study challenge the current consensus in cardiology that peak myocardial edema, or heart muscle swelling, only occurs just after a myocardial infarction, or heart attack. In the study, presented as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific Sessions 2014 and published simultaneously in the Journal of the American College of Cardiology (JACC), scientists discovered a second wave of swelling and inflammation occurs within a week of a heart attack.
The researchers from the Mount Sinai Heart at Icahn School of Medicine ...
2014-11-18
The findings of this international collaboration have been published today in Nature Genetics.
Progressive myoclonus epilepsies (PME) are rare, inherited, and usually childhood-onset neurodegenerative diseases whose core symptoms are epileptic seizures and debilitating involuntary muscle twitching (myoclonus).
Professor Berkovic said this finding of a new gene underlying progressive myoclonus epilepsy is one of the most devastating forms of epilepsy.
"For the study, we used modern DNA sequencing technologies, which have revolutionised genetic research of rare, severe ...
2014-11-18
Anyone who has struggled with a foggy brain while adjusting to daylight saving time knows first-hand how an out-of-sync circadian clock can impair brain function.
Now, by manipulating the circadian clocks of Siberian hamsters, Stanford scientists may have identified a brain structure that disrupts memory when circadian rhythms fall apart, as they often do in patients with neurodegenerative diseases such as Alzheimer's.
"What we've been able to show is that the part of the brain that we absolutely know contains the circadian clock, the suprachiasmatic nucleus (SCN), ...
2014-11-18
Adding just one gram of turmeric to breakfast could help improve the memory of people who are in the very early stages of diabetes and at risk of cognitive impairment.
The finding has particular significance given that the world's ageing population means a rising incidence of conditions that predispose people to diabetes, which in turn is connected to dementia.
Early intervention could help to reduce the burden, whether by halting the disease or reducing its impact, said Emeritus Professor Mark Wahlqvist, from the Monash Asia Institute at Monash University.
Professor ...
2014-11-18
Toddlers and tweens have very different needs, which influence how parents provide for them. The same is true in honey bees, but instead of communicating their needs via language, honey bee larvae emit chemical signals called pheromones that influence the behavior of their caregivers.
As larvae age, the diet they're fed changes. So too do the pheromone signals they emit. In a paper published in the advanced online edition of the journal Animal Behaviour, ASU alumna Kirsten Traynor, a research associate with the University of Maryland, Robert E. Page Jr., ASU university ...
2014-11-18
Cocaine users complaining of chest pain may have abnormal blood flow in the heart's smallest blood vessels that may not be detected in regular testing, putting these patients at risk for heart complications or death, according to research presented at the American Heart Association's Scientific Sessions 2014.
"Cocaine use is unfortunately very common, and we see many emergency room admissions because patients experience chest pain following cocaine use," said Varun Kumar, M.D., lead study author and an internist at Mount Sinai Hospital in Chicago. "But there can be a ...
2014-11-18
Adults whose mothers were overweight or obese before pregnancy have a dramatically elevated risk of dying from heart disease or stroke, according to a new study presented at the American Heart Association's Scientific Sessions 2014.
"Excess weight among young women of childbearing age has important implications not only for their own health, but for that of their children as well," said Michael Mendelson, M.D., S.M., the study's lead author and a research fellow at the Framingham Heart Study, Boston University and the Boston Children's Hospital.
Previous studies had ...
2014-11-18
Men who have asymptomatic subclinical vascular disease are more likely to develop erectile dysfunction than men who don't have early stage vascular disease, according to research presented at the American Heart Association's Scientific Sessions 2014.
"Erectile function can be a window into men's cardiovascular and overall health," said David I. Feldman, B.S., lead author and research assistant at the Ciccarone Center for the Prevention of Heart Disease at Johns Hopkins in Baltimore, Maryland. "Erectile dysfunction and cardiovascular disease commonly coexist."
Researchers ...
2014-11-18
High trans fat consumption is linked to worse memory among working-age men, according to research presented at the American Heart Association's Scientific Sessions 2014.
In a recent study of approximately 1,000 healthy men, those who consumed the most trans fats showed notably worse performance on a word memory test. The strength of the association remained even after taking into consideration things like age, education, ethnicity and depression.
"Trans fats were most strongly linked to worse memory, in young and middle-aged men, during their working and career-building ...
2014-11-18
Pregnant women with congenital heart disease had very low risks of arrhythmias (irregular heart beat) or other heart-related complications during labor and delivery, according to research presented at the American Heart Association's Scientific Sessions 2014.
However, such women were more likely to undergo cesarean section and remain in the hospital longer, researchers said.
"We are pleased to find the risk of complications are not as high as expected in women with congenital heart disease," said Robert M. Hayward, M.D., lead study author and a cardiac electrophysiology ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cardiac stem cell therapy may heal heart damage caused by Duchenne muscular dystrophy
Late-breaking basic science research presented at American Heart Association Scientific Sessions shows stem cell treatment restores heart function damaged by muscular disease
